Source: earnings_events
Changes History →Track the stock moves that actually matter.
BestStocks detects meaningful changes across price, volume, earnings, filings, valuation, analyst revisions, and risk signals — and shows you the evidence behind each one.
Investment research built around change detection.
BestStocks identifies what changed across companies and sectors, explains why it matters, and helps investors spot opportunities worth investigating.
What changed: Prologis, Inc. (PLD) reported EPS of $1.13 vs. consensus estimate of $0.75, beating by 51.3% on 2026-07-16.
Source: earnings_events
Changes History →Monitor PLD's next earnings announcement and any updates on occupancy rates, rental spreads, or capital deployment activity.
What changed: State Street Corporation (STT) reported EPS of $3.65 vs. consensus estimate of $3.30, beating expectations by 10.6% for Q2 FY2026 on July 16, 2026.
Source: earnings_events
Changes History →Monitor STT's guidance and commentary on net revenue, net interest margin, and asset-servicing client flows for signals about sustainability of the beat into Q3.
What changed: Commerce Bancshares, Inc. (CBSH) reported EPS of $1.10 vs. consensus estimate of $1.04, beating expectations by 5.8% when it announced Q2 FY2026 results on July 16, 2026.
Source: earnings_events
Changes History →Monitor CBSH's next earnings announcement and any management commentary on net interest margin trends and loan growth trajectories.
What changed: U.S. Bancorp (USB) reported EPS of $1.35 vs. consensus estimate of $1.28, beating expectations by 5.5% when results were announced on July 16, 2026.
Source: earnings_events
Changes History →Monitor USB's forward guidance and loan loss provisions in the earnings call for signals on third-quarter profitability trends.
What changed: GE Aerospace (GE) reported Q2 FY2026 EPS of $2.02, beating consensus estimate of $1.86 by 8.6% on 2026-07-16.
Source: earnings_events
Changes History →Monitor GE Aerospace's Q3 FY2026 earnings guidance and free cash flow trends for confirmation of sustained operational momentum.
What changed: Citizens Financial Group, Inc. (CFG) reported EPS of $1.30 vs. consensus estimate of $1.25, beating consensus by 4.0%.
Source: earnings_events
Changes History →Monitor CFG's next quarterly earnings report and any guidance updates on net interest margin trends or loan growth.
What changed: Vicor fell 8.30% to $238.59, reversing recent positive sentiment on AI infrastructure demand and capacity expansion. Despite analyst coverage highlighting the company's manufacturing expansion and valuation advantage over peers (Zacks, 2026-07-16), the stock declined on below-average volume of 187,843 shares (0.68x expected at this point in the session), suggesting limited conviction behind the move.
Detected Jul 16, 3:30 PM ET
Changes History →Intraday close and daily volume; any earnings catalyst or guidance update from Vicor or major AI infrastructure customers; sector moves in power management semiconductors.
What changed: Rocket Lab fell 8.99% to $69.35 in intraday trading with no identified catalyst in news or filings. The stock remains well below analyst consensus price target of $116.57 (per 16-analyst average as of July 2026), suggesting the decline may reflect broader market pressure or delayed reaction to prior events rather than new company-specific news.
Detected Jul 16, 3:30 PM ET
Changes History →Monitor for press releases, earnings announcements, or analyst downgrades after market hours; check volume and close-of-day price action to confirm whether the decline holds or reverses.
Corning Inc (GLW) fell 10.25% to $156.53 from $174.41 in intraday trading. No specific catalyst event was found in available sources; the stock was mentioned in a Zacks Industry Outlook article dated July 15, 2026, but this generic industry coverage does not explain today's sharp decline. Volume is running 29% above the 180-minute average, suggesting active selling.
Corning (GLW) dropped 7.13% to $161.98 after the company issued an unscheduled mid-quarter guidance cut, citing decelerating demand in carrier network and display technology segments, according to reporting on the July 16 update [3]. The decline was amplified by sector-wide de-risking as institutional investors rotated out of high-multiple hardware stocks following cautious cloud provider outlooks [3], and by reported executive insider selling [1].
Watch for official company statements, updated analyst ratings, or earnings/guidance announcements; also monitor optical communications and materials sector peers for correlated weakness.
Western Digital fell 8.59% to $469.69 on July 16, 2026, driven by sector-wide profit-taking in memory chips after a strong year-to-date rally, compounded by fresh competition concerns following Chinese rival CXMT's $10 billion Shanghai IPO filing. The decline reflects investor rotation out of overheated memory names amid fears of intensified pricing pressure in the cyclical market. Volume at 1.17x expected levels suggests orderly selling rather than panic.
Western Digital fell 5.1% to $487.72 as memory stocks tumbled on profit-taking and sector headwinds. Per Benzinga and 247wallst, the decline was driven by a global chip selloff hitting memory stocks after a strong rally, combined with concerns over slowing AI memory demand and fresh competition fears from Chinese rival CXMT's $10 billion Shanghai IPO filing. SK Hynix and SanDisk fell 5–6% on the same day, confirming sector-wide weakness amid a rising broader market.
Track CXMT's IPO pricing and listing date; monitor WDC and peer (Micron, SanDisk) earnings guidance for memory pricing commentary; watch for technical support around the recent 30-day lows.
What changed: Summit Therapeutics divested its late-stage antibiotic ridinilazole to Biossil for $105M in upfront cash, milestone payments, and royalties (announced July 15, per Zacks), as the company refocuses on oncology. The stock fell 9.59% to $13.63, with below-average volume (0.51x expected at 360 minutes into session), suggesting limited conviction behind either the sale or the market's interpretation of it.
Detected Jul 16, 3:30 PM ET
Changes History →Summit's Q2 2026 financial results and operational progress call on July 23, 2026, where management will detail the rationale, use of proceeds, and updated oncology pipeline strategy.











